Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Income Statement for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2014	12-2013	12-2012	12-2011	12-2010
Sales	4,676,500	2,602,500	5,914,900	4,584,400	3,566,900
Cost of Goods	1,704,800	1,644,700	3,394,300	2,566,500	1,998,500
Gross Profit	2,971,700	957,800	2,520,600	2,017,900	1,568,400
Operating Expenses	5,539,700	1,327,700	2,205,200	1,495,000	1,263,500
Operating Income	-2,567,200	-369,200	315,700	523,400	305,400
Interest Expense	411,800	239,800	111,600	69,000	84,100
Other Income	-19,200	-13,800	41,000	1,600	29,300
Pre-tax Income	-2,998,200	-622,800	245,100	456,000	250,600
Income Tax	-513,600	-155,300	146,800	196,900	67,300
Net Income Continuous	-2,484,600	-467,500	98,300	259,100	183,300
Net Income Discontinuous	854,100	-282,900	N/A	N/A	N/A
Minority Interests	N/A	N/A	1,000	-1,800	-1,100
Net Income	$-1,630,500	$-750,400	$97,300	$260,900	$184,400
EPS Basic Total Ops	-7.42	-5.27	0.77	2.10	1.51
EPS Basic Continuous Ops	-11.31	-3.29	0.78	2.08	1.50
EPS Basic Discontinuous Ops	3.89	-1.98	N/A	N/A	N/A
EPS Diluted Total Ops	-7.42	-5.27	0.76	2.06	1.48
EPS Diluted Continuous Ops	-11.31	-3.29	0.77	2.05	1.48
EPS Diluted Discontinuous Ops	3.89	-1.98	N/A	N/A	N/A
EPS Diluted Before Non-Recurring Items	13.98	N/A	N/A	N/A	N/A
EBITDA(a)	$1,334,200	$952,800	$1,000,500	$995,900	$587,300